Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2014
03/06/2014US20140065133 Jak/stat inhibitors and mapk/erk inhibitors for rsv infection
03/06/2014US20140065130 Method for treating premature ejaculation with a neurotoxin
03/06/2014US20140065128 TREATMENT FOR IgE-MEDIATED DISEASE
03/06/2014US20140065125 Pharmaceutical compositoin for treating depression and method for preparation thereof
03/06/2014US20140065121 Blood plasma based hydrogels for tissue regeneration and wound healing applications
03/06/2014US20140065120 Delivery of compounds with rehydrated blood cells
03/06/2014US20140065119 Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds
03/06/2014US20140065109 Use of substance p for mobilization of mesenchymal stem cells or proliferation of mesenchymal stem cells and for wound healing or facilitating wound healing
03/06/2014US20140065108 Tendon Stem Cells
03/06/2014US20140065107 Devices, systems, and methods for modulating uterine function
03/06/2014US20140065106 Blood Plasma Based Hydrogels for Tissue Regeneration and Wound Healing Applications
03/06/2014US20140065103 Compounds and methods for the treatment or prevention of flaviviridae viral infections
03/06/2014US20140065102 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014US20140065101 2'-Branched Nucleosides for Treatment of Viral Infections
03/06/2014US20140065096 Cancer therapy by ex vivo activated autologous immune cells
03/06/2014US20140065071 Sincalide Formulations
03/06/2014DE112012001839T5 Caspofungin oder Salze davon mit hoher Reinheit sowie Herstellungsverfahren und Verwendung dafür Caspofungin or salts thereof having high purity and preparation method and use it
03/06/2014DE102006059574B4 Verfahren und Reagenzien zur spezifischen Detektion von Autoantikörpern bei Patienten mit blasenbildenden Autoimmundermatosen Methods and reagents for the specific detection of autoantibodies in patients with autoimmune blistering skin diseases
03/06/2014CA2854927A1 The controlled release method for a pharmaceutical composition composed of chelating complex micelles
03/05/2014EP2703487A1 Peptide for inducing regeneration of tissue and use thereof
03/05/2014EP2703486A1 Anti-b7-h3 antibody
03/05/2014EP2703410A1 Jagaricin, derivatives, and uses thereof
03/05/2014EP2703409A1 Intermediate for synthesizing caspofungin and preparation method therefor
03/05/2014EP2703006A1 Use of regulator of calcineurin 1 for manufacturing medicament for treatment of diseases associated with increased nf- b activity
03/05/2014EP2703005A1 Inhibitors of alpha6 Integrin/E-Cadherin Complex
03/05/2014EP2702997A1 Method and composition for enhancing target cells uptake of therapeutic agents
03/05/2014EP2702069A2 Il4/il13 binding repeat proteins and uses
03/05/2014EP2701745A1 Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration
03/05/2014EP2701733A2 Compounds for the treatment of neuropsychiatric disorders
03/05/2014EP2701732A1 Lecithin:cholesterol acyltransferase (lcat) and its role in nonalcoholic fatty liver disease (nafld)
03/05/2014EP2701731A1 Intravascular delivery of nanoparticle compositions and uses thereof
03/05/2014EP2701730A2 Mfg-e8 and uses thereof
03/05/2014EP2701729A1 Hemostatic compositions
03/05/2014EP2701728A1 Formulation comprising crh and alpha - 2 - immunoglobulin
03/05/2014EP2701727A2 Locally released growth factors to mediate motor recovery after stroke
03/05/2014EP2701726A1 Novel polypeptides and use thereof
03/05/2014EP2701725A1 Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents
03/05/2014EP2701724A1 Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
03/05/2014EP2701723A2 Dna aptamers for promoting remyelination
03/05/2014EP2701722A2 Human myeloid derived suppressor cell cancer markers
03/05/2014EP2701721A2 Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
03/05/2014EP2701720A1 Lyophilized preparation of cytotoxic dipeptides
03/05/2014EP2701719A1 Method for treatment of macular degeneration by modulating p2y12 or p2x7 receptors
03/05/2014EP2701718A1 Lantibiotic nai-802, pharmaceutically acceptable salts, compositions, and uses thereof
03/05/2014EP2701716A1 Protein hydrolysates as agents for overcoming addiction
03/05/2014EP2701701A1 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
03/05/2014EP2701691A1 Composition for prevention and treatment of rheumatoid arthritis
03/05/2014EP2701686A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/05/2014CN103619874A Soluble integrin [alpha]4 mutant
03/05/2014CN103619413A Method to modulate pigmentation process in the melanocytes of skin
03/05/2014CN103619348A Compounds for the treatment of neuropsychiatric disorders
03/05/2014CN103619347A Freeze-dried formulations of FGF-18
03/05/2014CN103619344A A dietary supplement
03/05/2014CN103619327A Ocular drug delivery system
03/05/2014CN103619175A Double-acylated GLP-1 derivatives
03/05/2014CN103614399A Eriocheir sinensis lysozyme gene, encoding protein and application thereof
03/05/2014CN103614386A Halostachys caspica metallothionein gene as well as recombinant protein and application thereof
03/05/2014CN103613668A Long-acting fusion interferon for dogs and cats, as well as preparation method and application thereof
03/05/2014CN103613657A Exendin4 with shortened peptide chain and genetic engineering application thereof
03/05/2014CN103613645A Antioxidant peptide sourced from limnonectes fragilis as well as gene and application thereof
03/05/2014CN103613644A Small peptide lactotransferrin (LTF) with anti-tumor effect and application thereof
03/05/2014CN103611214A Needle drug microsystem and preparation method thereof
03/05/2014CN103611196A PELA/BMP-2 microsphere and preparation method
03/05/2014CN103611167A Application of miR-106a in inhibiting expression and glucose uptake of glioma cell SLC2A3
03/05/2014CN103611163A Anticancer medicine composition containing interferon alpha-conjugate
03/05/2014CN103611162A Freeze-drying protective agent for human blood coagulation factor VIII and preparation method of freeze-drying protective agent
03/05/2014CN103611155A Australia tea tree effervescent tablet and preparation method thereof
03/05/2014CN103611154A Lophius litulon skin collagen peptide composition capable of resisting gram negative bacteria
03/05/2014CN103611153A Use of neuregulin 1
03/05/2014CN103611152A Compound vitamin D electuary
03/05/2014CN103611151A Application of circumsporozoite protein polypeptide CSP I-plus of plasmodium in preparing anti-malarial medicine
03/05/2014CN103611150A Application of circumsporozoite protein polypeptide CSP I-plus of plasmodium in preparing medicine for resisting hepatitis virus
03/05/2014CN103611149A Pentapeptide metabolite and application of pentapeptide metabolite in preparation of medicament for preventing and treating ischemic cerebrovascular diseases
03/05/2014CN103610652A Preparation method of alanyl-glutamine freeze-dried powder
03/05/2014CN103610063A Kenneth Lonergan marrow mixture and preparation method thereof
03/05/2014CN103610048A Health-care food with assistant protecting function to chemical liver injury and preparation method thereof
03/05/2014CN103073617B N-(2)-L-alanyl-L-glutamine compound
03/05/2014CN102600451B Felodipine ramipril compound sustained-release preparation and preparation method thereof
03/05/2014CN102413835B Sustained release formulations containing GnRH analogue
03/05/2014CN102172262B Enzyme treatment for infection
03/04/2014US8666680 Recombinant soluble FC receptors
03/04/2014US8664471 Rapidly maturing fluorescent proteins and methods for using the same
03/04/2014US8664369 LH liquid formulations
03/04/2014US8664360 BSL3 polypeptides
03/04/2014US8664355 Cell-free protein synthesis method with the use of linear template DNA and cell extract therefor
03/04/2014US8664354 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
03/04/2014US8664273 Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin
03/04/2014US8664211 Modified amino acid for the inhibition of platelet aggregation
03/04/2014US8664184 Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer
03/04/2014US8664183 SPANX-B polypeptides and their use
03/04/2014US8664182 Methods of inhibiting cancer cell growth with HDAC inhibitors and methods of screening for HDAC10 inhibitors
03/04/2014US8664181 Dual acting prodrugs
03/04/2014US8664180 Ophthalmic compositions containing diglycine
03/04/2014US8664178 Peptide pharmaceutical for oral delivery
03/04/2014US8664177 Peptide compositions and methods for treating patients
03/04/2014US8664176 Treatment for age-related macular degeneration and other diseases of the eye
03/04/2014US8663971 Protein glycosylation modification in methylotrophic yeast
03/04/2014US8663964 Methods of treating human papillomavirus
03/04/2014US8663963 Hafnia phytase
03/04/2014US8663916 Methods for producing antifungal bifunctional molecules for treating fungal infection
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 3163